Français
6. Biochips market
Biochips were developed and marketed in the 1990s. Since then, the market has undergone tremendous growth. Valued at $760 million in 2010, it is expected to reach $1,425.2 million by 2015. The Morgan Stanley report of May 2010 shows that the microarray market is essentially held by three companies. Affymetrix, the main industry leader in microarrays and associated reagents, accounts for 38% of market share, Illumina for 34% and Agilent for 17% (figure 16 and table 3 ). Competition is fierce, and Roche/NimbleGen, which holds just 5.5% of the market, has decided to cease its microarray business by the end of 2012, in order to focus on sequence capture and next-generation sequencing. The "gene expression" application...
The Ultimate Scientific and Technical Reference
This article is included in
Healthcare technologies
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Biochips market
Biochip pitfalls and solutions
Bibliography
Websites
Journal Lab-on-a-Chip https://www.rsc.org/journals-books-databases/about-journals/lab-on-a-chip/
Biochips Bionanotechnologies team http://www.lisbp.fr/fr/la_recherche/axe_physiologie_et_metabolisme_...
Events
Lab-on-a-Chip World Congress http://www.selectbiosciences.com/conferences
microTAS http://www.microtas12.org/
Directory
Manufacturers – Suppliers – Distributors (non-exhaustive list)
Manufacturer of biochips and associated robots
Affymetrix http://www.affymetrix.com/estore/
Agilent http://www.genomics.agilent.com/
Arrayit...
Statistical and economic data
Global DNA and Gene Chip (Microarrays) Market (2010-2015) http://www.marketsandmarkets.com/Market-Reports/genechips-367.html
The Ultimate Scientific and Technical Reference
